Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
2022 · Drug Resistance Updates · 220 citations
https://doi.org/10.1016/j.drup.2022.100907
Z
Zhenduo Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
6.0K
Citations
18
h-index
34
i10-index
Zhenduo Shi is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Research and Treatments & Epigenetics and DNA Methylation. The author has an h-index of 18, co-authored 92 publications.
ORCID: 0000-0002-2416-4291Papers by this author
worksIdentification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma
2021 · BMC Cancer · 24 citations
https://doi.org/10.1186/s12885-021-08818-0
Research Advances in Stem Cell Therapy for Erectile Dysfunction
2024 · BioDrugs · 17 citations
https://doi.org/10.1007/s40259-024-00650-9
MAP30 Inhibits Bladder Cancer Cell Migration and Invasion <i>In Vitro</i> Through Suppressing Akt Pathway and the Epithelial/Mesenchymal Transition Process
2020 · DNA and Cell Biology · 13 citations
https://doi.org/10.1089/dna.2020.5469
Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression
2023 · Biomarker Research · 13 citations
https://doi.org/10.1186/s40364-023-00488-3
Associations between metabolic syndrome and erectile dysfunction: evidence from the NHANES 2001–2004
2025 · Frontiers in Public Health · 6 citations
https://doi.org/10.3389/fpubh.2025.1543668
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat